1. A case report of fulminant hepatitis due to ribociclib with confirmed by liver biopsy in breast cancer. (January 2022) Authors: Topcu, Atakan; Yasin, Ayse Irem; Shbair, Abdallah TM; Besiroglu, Mehmet; Simsek, Melih; Sucuoglu, Zehra; Yurtsever, Ismail; Gucin, Zuhal; Seker, Mesut; Turk, Haci Mehmet Journal: Journal of oncology pharmacy practice Issue: Volume 28:Number 1(2022) Page Start: 242 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 study. Issue 11 (November 2022) Authors: Wainberg, Zev A; Enzinger, Peter C; Kang, Yoon-Koo; Qin, Shukui; Yamaguchi, Kensei; Kim, In-Ho; Saeed, Anwaar; Oh, Sang Cheul; Li, Jin; Turk, Haci Mehmet; Teixeira, Alexandra; Borg, Christophe; Hitre, Erika; Udrea, Adrian A; Cardellino, Giovanni Gerardo; Sanchez, Raquel Guardeño; Collins, Helen; ... Journal: Lancet oncology Issue: Volume 23:Issue 11(2022) Page Start: 1430 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The efficacy of BNT162b2 (Pfizer–BioNTech) and CoronaVac vaccines in patients with cancer. Issue 9 (14th May 2022) Authors: Simsek, Melih; Yasin, Ayse I.; Besiroglu, Mehmet; Topcu, Atakan; Sucuoglu Isleyen, Zehra; Seker, Mesut; Turk, Haci Mehmet Journal: Journal of medical virology Issue: Volume 94:Issue 9(2022) Page Start: 4138 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗